Human Insulin Market Research Report: Information by Type Traditional Human Insulin and Modern Human Insulin, by Indication Type 1 Diabetes and Type 2 Diabetes, and by End-User Hospitals and Clinics and Research Institutes – Global Forecast Till 2023
Global Human Insulin Market – Scenario:
Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used.
Get Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/951
Global Human Insulin Market – Highlights
North America and EU regions are dominating the market over a period of time while, Asia is the fastest growing region for Human insulin Market in coming years
Increasing prevalence of diabetes and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. Diabetes has become one of the major public health problems in North America, due to increasing number of geriatric population and rising prevalence of obesity.
Diabetes is the major public health threat for the world. Prevalence of Type 2 diabetes is increasing rapidly in Asia-Pacific. According to a study conducted by National Centre for Biotechnology Information in 2012, approximately 60% of Asian population was suffering from diabetes. China is expected to have highest prevalence rate of diabetes, followed by India, due to rise in industrialization, urbanization and westernization.
Global Human Insulin Market – Segments:
Global Human Insulin market has been segmented on the basis of types which majorly includes modern human insulin, and traditional human insulin. The modern human insulin is further divided into; long acting human insulin, rapid acting human insulin, and premixed human insulin. Whereas, the traditional human insulin is again categorized into; short acting human insulin, and intermediate acting human insulin.
Global Human Insulin Market – Key Players
Biocon Ltd. (India), Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Adocia (France.), Merck & Co. (U.S.), Julphar (UAE), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline Plc (U.K.), Oramed Pharmaceuticals, Inc. (Israel), Novo Nordisk A/S (Denmark), and others.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/human-insulin-market-951
Global Human Insulin Market – Key Findings
Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region
Based on the type, modern human insulin has the largest market share in the human insulin market
Regional Analysis of Human Insulin Market:
Rest of Western Europe
Rest of Asia
MAJOR TABLE OF CONTENTS:
1 REPORT PROLOGUE
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 Human Insulin Market 2016-2020: BY types (US $ MILLION)
7 Human Insulin Market, by Region Market Value & Volume Forecast (US $ MILLION)
8 COMPANY LANSCAPE
9 COMPANY PROFILE
Major TOC Continued…!
Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/951
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312